I lead the HTA and Market Access Operations team at Putnam, where I advise biopharmaceutical companies from early-phase asset planning through launch. My expertise lies in European payers and health technology assessments (HTAs), helping clients navigate complex market access landscapes.

With over 15 years of experience leading HEOR teams at both local and global levels in the pharmaceutical industry (across the US and EU), I have also spent more than five years as an Executive VP in market access consulting.

I hold an MSc in Health Economics and a PhD in Health Sciences, and I have authored over 200 articles, communications, and posters in the fields of HEOR, market access, and epidemiology.